MedPath

Endoscopy-Assisted Tracheal Intubation Versus Conventional Tracheal Intubation for Endoscopic Submucosal Dissection (ESD): a Prospective Randomized Controlled Study

Not Applicable
Not yet recruiting
Conditions
Tracheal Intubation
Endoscopic Submucosal Dissection
Endoscopy-Assisted
Video Laryngoscope
Registration Number
NCT06730984
Lead Sponsor
Ningbo No. 1 Hospital
Brief Summary

This study plans to enroll 148 patients undergoing upper gastrointestinal endoscopic submucosal dissection (ESD). Patients will be randomly divided into a control group (conventional tracheal intubation) and an experimental group (endoscopy-assisted tracheal intubation). Patients meeting the inclusion criteria and not falling under the exclusion criteria will be invited to participate in the study. Upon providing voluntary consent, the research physician will arrange for the patient's inclusion in the study. After signing the informed consent form, the research physician will collect the patient's basic information, medical history, and other details, followed by timing the preoperative preparation period and evaluating postoperative discomfort

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
132
Inclusion Criteria
  • Patients undergoing endoscopic submucosal dissection (ESD) at Ningbo University Affiliated First Hospital from December 2024 to December 2026.
  • Aged between 18 and 75 years.
  • Patients who voluntarily agree to participate in the study and sign the informed consent form.
Exclusion Criteria
  • Individuals under 18 years of age.
  • Patinents unwilling or unable to provide informed consent.
  • Patients with severe chronic cardiac or pulmonary disease, or those who have required hospitalization for coronary or cerebrovascular events or radiotherapy within the past 3 months.
  • Patients with severe abdominal symptoms such as severe pain, bloating, or nausea.
  • Patients with inadequate preoperative preparation.
  • Individuals requiring lifelong anticoagulant therapy, those with severe bleeding disorders, or those who have recently taken anticoagulant or antiplatelet medications.
  • Pregnant or breastfeeding individuals.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
preoperative preparation time10 mins

the time from Initiate Anesthesia Induction to Insert the Therapeutic Endoscope into the Oral Cavity

Secondary Outcome Measures
NameTimeMethod
The time to view the vocal cords (TVVC)1 min

the time from inserting the tracheal tube into mouth to the operator view the the entire vocal cords

The time to advance the tracheal tube into trachea (TATT)1 min

the time from viewing the entire vocal cords to insert the tracheal tube into trachea successfully

Trial Locations

Locations (1)

the First Affiliated Hospital of Ningbo University

🇨🇳

Ningbo, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath